Authors: CHOC MG MUELLER EA ROBINSON WT KUMLE A SMITH HT CHARNICK SB

Citation: Mg. Choc et al., RELATIVE BIOAVAILABILITY OF NEORAL VERSUS SANDIMMUNE IN THE PRESENCE OF A P450IIIA AND P-GLYCOPROTEIN INHIBITOR, Transplantation proceedings, 30(5), 1998, pp. 1664-1665

Authors: APPEL S KUMLE A HUBERT M DUVAUCHELLE T

Citation: S. Appel et al., FIRST PHARMACOKINETIC-PHARMACODYNAMIC STUDY IN HUMANS WITH A SELECTIVE 5-HYDROXYTRYPTAMINE(4) RECEPTOR AGONIST, Journal of clinical pharmacology, 37(3), 1997, pp. 229-237

Authors: APPEL S KUMLE A MEIER R

Citation: S. Appel et al., CLINICAL PHARMACODYNAMICS OF SDZ HTF-919, A NEW 5-HT4 RECEPTOR AGONIST, IN A MODEL OF SLOW COLONIC TRANSIT, Clinical pharmacology and therapeutics, 62(5), 1997, pp. 546-555

Authors: APPEL S LEMARECHAL MO KUMLE A HUBERT M LEGANGNEUX E

Citation: S. Appel et al., SIMULTANEOUS PO AND IV PHARMACOKINETIC MODELING OF THE NOVEL SELECTIVE 5-HT4 RECEPTOR AGONIST SDZ HTF-919 IN HUMANS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 85-85